Search by Drug Name or NDC
NDC 24765-0109-01 Cellzyme Secret Therapy .145; 5.2; 1.925 g/100mL; g/100mL; g/100mL Details
Cellzyme Secret Therapy .145; 5.2; 1.925 g/100mL; g/100mL; g/100mL
Cellzyme Secret Therapy is a TOPICAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by PHARMACAL-INTERNATIONAL. CO., LTD. The primary component is ALLANTOIN; GLYCERIN; HYDROXYETHYL ETHYLCELLULOSE.
Product Information
| NDC | 24765-0109 |
|---|---|
| Product ID | 24765-109_03245ecc-f065-f36b-e063-6294a90aa9fc |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Cellzyme Secret Therapy |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | GLYCERIN,HYDROXYETHYL ETHYLCELLULOSE ,ALLANTOIN |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | LIQUID |
| Route | TOPICAL |
| Active Ingredient Strength | .145; 5.2; 1.925 |
| Active Ingredient Units | g/100mL; g/100mL; g/100mL |
| Substance Name | ALLANTOIN; GLYCERIN; HYDROXYETHYL ETHYLCELLULOSE |
| Labeler Name | PHARMACAL-INTERNATIONAL. CO., LTD |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 24765-0109-01 (24765010901)
| NDC Package Code | 24765-109-01 |
|---|---|
| Billing NDC | 24765010901 |
| Package | 3 mL in 1 BOTTLE (24765-109-01) |
| Marketing Start Date | 2017-08-16 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |